Dina Stroopinsky

1.9k total citations
46 papers, 835 citations indexed

About

Dina Stroopinsky is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dina Stroopinsky has authored 46 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 19 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Dina Stroopinsky's work include Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Dina Stroopinsky is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Dina Stroopinsky collaborates with scholars based in United States, Israel and Italy. Dina Stroopinsky's co-authors include David Avigan, Jacalyn Rosenblatt, Donald Küfe, Irit Avivi, Tamar Katz, Jacob M. Rowe, Jon Arnason, Katarina Luptakova, Eleni Anastasiadou and Frank J. Slack and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Dina Stroopinsky

45 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Stroopinsky United States 14 392 315 295 193 144 46 835
Rachel Koldej Australia 17 293 0.7× 162 0.5× 247 0.8× 158 0.8× 99 0.7× 59 771
Hyung‐Gyoon Kim United States 17 541 1.4× 197 0.6× 405 1.4× 121 0.6× 189 1.3× 33 1.0k
Axel Mischo Switzerland 17 427 1.1× 284 0.9× 339 1.1× 66 0.3× 136 0.9× 40 900
Sanfang Tu China 16 297 0.8× 201 0.6× 582 2.0× 166 0.9× 57 0.4× 52 858
Brian J. Sworder United States 12 316 0.8× 250 0.8× 237 0.8× 64 0.3× 94 0.7× 34 719
Xiaojian Zhu China 18 535 1.4× 163 0.5× 426 1.4× 162 0.8× 220 1.5× 68 959
Mingqing Zhu China 11 246 0.6× 380 1.2× 439 1.5× 278 1.4× 65 0.5× 53 809
Peet Nooijen Netherlands 13 341 0.9× 161 0.5× 279 0.9× 43 0.2× 146 1.0× 30 844
Mobin Karimi United States 11 291 0.7× 524 1.7× 414 1.4× 198 1.0× 46 0.3× 32 927
Sijie Lu United States 14 254 0.6× 904 2.9× 688 2.3× 172 0.9× 60 0.4× 25 1.3k

Countries citing papers authored by Dina Stroopinsky

Since Specialization
Citations

This map shows the geographic impact of Dina Stroopinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Stroopinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Stroopinsky more than expected).

Fields of papers citing papers by Dina Stroopinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Stroopinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Stroopinsky. The network helps show where Dina Stroopinsky may publish in the future.

Co-authorship network of co-authors of Dina Stroopinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Stroopinsky. A scholar is included among the top collaborators of Dina Stroopinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Stroopinsky. Dina Stroopinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Ling, Dina Stroopinsky, Giulia Cheloni, et al.. (2022). Personalized tumor vaccine for pancreatic cancer. Cancer Immunology Immunotherapy. 72(2). 301–313. 11 indexed citations
2.
Stroopinsky, Dina, Anita G. Koshy, Myrna Nahas, et al.. (2021). Treatment with DC/AML Fusion Vaccine and CD3xCD123 Bi-Specific T-Cell Engager (CD123-CODV-TCE) for Treatment of Acute Myeloid Leukemia. Blood. 138(Supplement 1). 904–904.
3.
Anastasiadou, Eleni, Anita G. Seto, Xuan Beatty, et al.. (2020). Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo. Clinical Cancer Research. 27(4). 1139–1149. 110 indexed citations
4.
Capelletti, Marzia, Maria Themeli, Tuna Mutis, et al.. (2020). Potent Synergy between Combination of Chimeric Antigen Receptor (CAR) Therapy Targeting CD19 in Conjunction with Dendritic Cell (DC)/Tumor Fusion Vaccine in Hematological Malignancies.. Biology of Blood and Marrow Transplantation. 26(3). S42–S43. 4 indexed citations
5.
Capelletti, Marzia, Dina Stroopinsky, Myrna Nahas, et al.. (2020). Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma. Biology of Blood and Marrow Transplantation. 26(3). S316–S316. 3 indexed citations
6.
Anastasiadou, Eleni, Dina Stroopinsky, Stella Alimperti, et al.. (2018). Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia. 33(1). 132–147. 129 indexed citations
7.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2017). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Molecular Cancer Therapeutics. 16(10). 2304–2314. 10 indexed citations
8.
Bar‐Natan, Michal, Dina Stroopinsky, Katarina Luptakova, et al.. (2017). Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. British Journal of Haematology. 176(6). 929–938. 23 indexed citations
9.
Stroopinsky, Dina, Donald Küfe, & David Avigan. (2016). MUC1 in hematological malignancies. Leukemia & lymphoma. 57(11). 2489–2498. 27 indexed citations
10.
Jain, Salvia, Abigail Washington, Rebecca Karp Leaf, et al.. (2016). Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma. Blood. 128(22). 4175–4175. 1 indexed citations
11.
Jain, Salvia, Dina Stroopinsky, Yin Li, et al.. (2015). Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood. 126(3). 354–362. 28 indexed citations
12.
Nahas, Myrna, Dina Stroopinsky, Hasan Rajabi, et al.. (2015). MUC1 Inhibition Overcomes Chemotherapy Resistance in Acute Myeloid Leukemia. Blood. 126(23). 2473–2473. 2 indexed citations
13.
Stroopinsky, Dina, Jacalyn Rosenblatt, Keisuke Ito, et al.. (2013). MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells. Cancer Research. 73(17). 5569–5579. 41 indexed citations
14.
Avivi, Irit, Dina Stroopinsky, & Tamar Katz. (2013). Anti-CD20 monoclonal antibodies: Beyond B-cells. Blood Reviews. 27(5). 217–223. 43 indexed citations
15.
Luptakova, Katarina, Jacalyn Rosenblatt, Dina Stroopinsky, et al.. (2013). Co-Expression Of The MUC1 Oncoprotein and CD34 On Primary Myeloma Bone Marrow Cells Identifies a Population With Myeloma Initiating Potential. Blood. 122(21). 127–127. 1 indexed citations
16.
Vasir, Baldev, Hasan Rajabi, Heidi Mills, et al.. (2013). STAT3 Inhibition Promotes Potent Th1 Responses By Down Regulating Pdl-1 Expression On Tumor Cells. Blood. 122(21). 3217–3217. 1 indexed citations
17.
Avivi, Irit, Dina Stroopinsky, Jacob M. Rowe, & Tamar Katz. (2012). A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management. Transplant Immunology. 28(1). 57–61. 11 indexed citations
18.
Stroopinsky, Dina, Tamar Katz, Jacob M. Rowe, Doron Melamed, & Irit Avivi. (2012). Rituximab-induced direct inhibition of T-cell activation. Cancer Immunology Immunotherapy. 61(8). 1233–1241. 50 indexed citations
19.
Luptakova, Katarina, Jacalyn Rosenblatt, Brett Glotzbecker, et al.. (2012). Lenalidomide enhances anti-myeloma cellular immunity. Cancer Immunology Immunotherapy. 62(1). 39–49. 132 indexed citations
20.
Stroopinsky, Dina, Irit Avivi, Jacob M. Rowe, David Avigan, & Tamar Katz. (2009). Allogeneic induced human FOXP3+IFN‐γ+ T cells exhibit selective suppressive capacity. European Journal of Immunology. 39(10). 2703–2715. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Koldej Breakdown of academic impact, for papers by Hyung‐Gyoon Kim Breakdown of academic impact, for papers by Axel Mischo Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Brian J. Sworder Breakdown of academic impact, for papers by Xiaojian Zhu Breakdown of academic impact, for papers by Mingqing Zhu Breakdown of academic impact, for papers by Peet Nooijen Breakdown of academic impact, for papers by Mobin Karimi Breakdown of academic impact, for papers by Sijie Lu
Rankless by CCL
2026